Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Inv. presentation
Quarterly results

BiomX Inc. (PHGE) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/23/2023 4 Marks Jason M. (Director) has filed a Form 4 on BiomX Inc.
Txns: Granted 41,000 options to buy @ $0.363, valued at $14.9k
08/23/2023 4 Dambach Michael E. (Director) has filed a Form 4 on BiomX Inc.
Txns: Granted 41,000 options to buy @ $0.363, valued at $14.9k
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
07/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
07/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
06/12/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/09/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
06/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
06/08/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/24/2023 4 Oron Assaf (Chief Business Officer) has filed a Form 4 on BiomX Inc.
Txns: Bought 3,192 shares @ $0.2731, valued at $871.7
05/19/2023 3 Marks Jason M. (Director) has filed a Form 3 on BiomX Inc.
05/19/2023 3 Dambach Michael E. (Director) has filed a Form 3 on BiomX Inc.
05/15/2023 8-K Quarterly results
Docs: "BiomX Reports First Quarter 2023 Financial Results and Provides Business Update"
05/08/2023 SC 13D/A OrbiMed Israel BioFund GP Limited Partnership reports a 9.9% stake in BiomX Inc.
05/05/2023 8-K Quarterly results
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/01/2023 ARS Form ARS - Annual Report to Security Holders:
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/25/2023 8-K Quarterly results
03/29/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/29/2023 10-K Annual Report for the period ended December 31, 2022
03/29/2023 8-K Quarterly results
03/22/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/17/2023 4 OrbiMed Israel BioFund GP Limited Partnership (10% Owner) has filed a Form 4 on BiomX Inc.
Txns: Bought 348,000 shares @ $0.245, valued at $85.3k
Bought 1,789,959 warrants @ $0.244, valued at $436.7k
03/17/2023 SC 13D/A OrbiMed Israel BioFund GP Limited Partnership reports a 10.5% stake in BiomX Inc.
03/09/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/08/2023 SC 13G Cystic Fibrosis Foundation reports a 8.1% stake in BiomX Inc.
02/27/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Pre-Funded Warrant"
02/22/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, ...
Docs: "FORM OF PRE-FUNDED WARRANT",
"FORM OF SECURITIES PURCHASE AGREEMENT DATED FEBRUARY 22, 2023",
"FORM OF REGISTRATION RIGHTS AGREEMENT",
"INVESTOR PRESENTATION DATED FEBRUARY 22, 2023"
02/14/2023 SC 13G/A MMCAP International Inc. SPC reports a 7.1% stake in BiomX Inc.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "INVESTOR PRESENTATION DATED JANUARY 26, 2023"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy